Resident Medical Reviewer · Family Medicine Physician and Integrative Wellness Specialist
View full credentials →Dr. Blane Schilling, MD is a family medicine physician and integrative wellness specialist with 30 years of clinical experience. He reviews medically sensitive articles for medical accuracy, safety context, contraindications, evidence quality, and practical reader risk across supplements, procedures, treatments, and wellness topics.
Key takeaways
- What does the Snacks data show?
- Which Snacks products should be reviewed first?
- Which Snacks products have stronger signals?
- What evidence gaps remain in Snacks?
What does the Snacks data show?
The Snacks category currently covers 41 products across 17 brands in the NonToxic.com database. 3 products are classified as elevated or highest concern, while 1 products are classified as lower concern based on the available safety score, contaminant fields, source label, and test year.
This Snacks guide is designed to be used with the category database page, not as a toxin-free certification. Scores are comparative safety signals that help shoppers decide which products deserve closer source review, brand questions, or substitution.
Which Snacks products should be reviewed first?
The first products to review in Snacks are the records with the lowest comparative safety scores or the weakest evidence fields. High-concern records should be checked for source quality, test year, packaging context, and whether a lower-concern alternative exists in the same category.
- RXBAR 10g Protein Bar Blueberry Cashew Butter by Rxbar: Elevated concern, 55/100.
- RXBAR 12g Protein Bar Blueberry by Rxbar: Elevated concern, 55/100.
- RXBAR 12g Protein Bar Strawberry by Rxbar: Elevated concern, 55/100.
- KIND Dark Chocolate Nuts & Sea Salt Bar by Kind: Moderate concern, 72/100.
- M&M's Peanut Chocolate Candies Sharing Size by M&M'S: Moderate concern, 72/100.
- Haribo Goldbears by Haribo: Moderate concern, 75/100.
Database action
Check the product database before changing purchases.
Use scores, concern levels, source quality, and category alternatives together.
Search productsWhich Snacks products have stronger signals?
Lower-concern Snacks records are useful starting points, but they still need source review. A stronger score is most useful when it is backed by a clear study source, a recent test year, and visible DEHP or microplastics fields.
- Sour Patch Kids Original Soft & Chewy by Sour: Lower concern, 82/100.
- Ritz Crackers Original by Ritz: Moderate concern, 78/100.
- Haribo Goldbears by Haribo: Moderate concern, 75/100.
- KIND Dark Chocolate Nuts & Sea Salt Bar by Kind: Moderate concern, 72/100.
- M&M's Peanut Chocolate Candies Sharing Size by M&M'S: Moderate concern, 72/100.
- RXBAR 10g Protein Bar Blueberry Cashew Butter by Rxbar: Elevated concern, 55/100.
What evidence gaps remain in Snacks?
0 Snacks records need more specific source normalization, and 8 records contain at least one missing, unknown, unavailable, or not-tested evidence field. These gaps should drive brand transparency requests and source-ingestion priorities before any product is treated as definitively safer.
The most common source labels in this category are Source verification pending (33), PlasticList (plasticlist.org) (8). Normalizing these labels into source URLs is the next data enrichment step.
How should shoppers use the Snacks guide?
Use the Snacks category page to compare all products, then open individual product pages for contaminant fields and evidence confidence. Daily-use products, products used by children or pregnant people, and food-contact products deserve stricter source review.
If a Snacks product is missing or has weak evidence, submit a source correction or retest request so the generated product page, schema, sitemap, and llms.txt entry can be updated from the same source of truth.
Resident Medical Reviewer · Family Medicine Physician and Integrative Wellness Specialist
View full credentials →Dr. Blane Schilling, MD is a family medicine physician and integrative wellness specialist with 30 years of clinical experience. He reviews medically sensitive articles for medical accuracy, safety context, contraindications, evidence quality, and practical reader risk across supplements, procedures, treatments, and wellness topics.